RxDoctor Payments Data

Kristoffer Guerrero, APRN

Psychiatric/Mental Health · Sylmar, CANPI 1699554568

Payments from drug & device makers

$3,363in general payments, 2019–2025

Across 152 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$518
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$440
  • AbbVie$306
  • Lundbeck LLC$213
  • Noven Therapeutics, LLC$209
  • Alkermes, Inc.$209
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,363100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,363 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Medicare billing

Part B allowed, 2024
$43,222
Medicare patients
163
Services billed
486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl24$36,238
Aripiprazole33$2,172
Bupropion XlBupropion Hcl81$1,784
Vilazodone Hcl15$1,677
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,567
Doxepin Hcl32$1,498
Duloxetine Hcl69$1,265
Quetiapine Fumarate68$1,119
Clonazepam111$984
Venlafaxine Hcl ErVenlafaxine Hcl69$912
Alprazolam134$898
Atomoxetine Hcl17$886
Buspirone Hcl73$825
Bupropion Hcl41$750
Quetiapine Fumarate ErQuetiapine Fumarate11$695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$306$36,23824 claims
Almatica Pharma LLCSertraline Hcl$177$65755 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Sylmar

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →